| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K30748066 |
| PharmacoGx | BRD-K30748066 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MDM4 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.01 |
| mRNA | RBM25 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.01 |
| mRNA | FLII | CTRPv2 | pan-cancer | AAC | -0.29 | 0.01 |
| mRNA | MYADM | CTRPv2 | pan-cancer | AAC | -0.34 | 0.01 |
| mRNA | FPGT | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | FBXO42 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.01 |
| mRNA | MRPL1 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.01 |
| mRNA | TJP2 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.01 |
| mRNA | SLC25A44 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.01 |
| mRNA | IL6R | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
